Who owns IKENA ONCOLOGY INC?
- Ticker: IKNA
- CUSIP Number: 45175g108
Tip: Access positions for across all investors
Analyze quarterly positions in Ikena Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ikena Oncology stock
Who bought or sold IKENA ONCOLOGY INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 5.0M | $8.2M | 0% | Dec 2024 |
|
| Blue Owl Capital Holdings | 4.1M | $6.7M | 0% | Dec 2024 |
|
| BVF | 4.0M | $6.6M | -16% | Dec 2024 |
|
| BML Capital Management | 3.6M | $5.9M | 396% | Dec 2024 |
|
| OrbiMed Advisors | 3.5M | $5.8M | 0% | Dec 2024 |
|
| Omega Fund Management | 2.2M | $3.7M | 0% | Dec 2024 |
|
| Gilead Sciences | 2.0M | $3.3M | 100% | Dec 2024 |
|
| Vanguard Group | 1.4M | $2.3M | 0% | Dec 2024 |
|
| Adage Capital Partners GP | 800k | $1.3M | -19% | Dec 2024 |
|
| NEA Management Company | 600k | $984k | 0% | Dec 2024 |
|
| Peapod Lane Capital | 508k | $833k | 100% | Dec 2024 |
|
| Sofinnova Ventures | 383k | $628k | 0% | Dec 2024 |
|
| BlackRock | 352k | $578k | 0% | Dec 2024 |
|
| Renaissance Technologies | 330k | $542k | -18% | Dec 2024 |
|
| Geode Capital Management | 328k | $538k | 21% | Dec 2024 |
|
| Jacobs Levy Equity Management | 327k | $537k | -16% | Dec 2024 |
|
| Acadian Asset Management | 288k | $471k | -11% | Dec 2024 |
|
| Millennium Management | 200k | $328k | -20% | Dec 2024 |
|
| Barclays | 195k | $320k | 0% | Dec 2024 |
|
| Two Sigma Advisers | 157k | $258k | -22% | Dec 2024 |
|
| Jpmorgan Chase & Co | 156k | $255k | 18244% | Dec 2024 |
|
| Bridgeway Capital Management | 154k | $252k | -3% | Dec 2024 |
|
| Two Sigma Investments | 101k | $165k | -36% | Dec 2024 |
|
| State Street Corporation | 92k | $151k | 15% | Dec 2024 |
|
| Deuterium Capital Management | 81k | $132k | 0% | Dec 2024 |
|
| Citadel Advisors | 80k | $132k | -51% | Dec 2024 |
|
| JBF Capital | 73k | $119k | 0% | Dec 2024 |
|
| UBS Group | 72k | $118k | 99700% | Dec 2024 |
|
| BBR Partners | 70k | $115k | -46% | Dec 2024 |
|
| Northern Trust | 58k | $94k | 20% | Dec 2024 |
|
| Goldman Sachs Group | 47k | $77k | -20% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 44k | $72k | 100% | Dec 2024 |
|
| Squarepoint Ops | 44k | $72k | 100% | Dec 2024 |
|
| Dimensional Fund Advisors | 39k | $63k | 0% | Dec 2024 |
|
| Vazirani Asset Management | 25k | $41k | -78% | Dec 2024 |
|
| Point72 Asia | 21k | $35k | -4% | Dec 2024 |
|
| Berkshire Asset Management | 20k | $30k | 0% | Dec 2024 |
|
| Engineers Gate Manager | 19k | $31k | 100% | Dec 2024 |
|
| Prudential Financial | 18k | $30k | -39% | Dec 2024 |
|
| JustInvest | 16k | $27k | -8% | Dec 2024 |
|
| Morgan Stanley | 15k | $23k | 0% | Dec 2024 |
|
| XTX Topco | 13k | $21k | 100% | Dec 2024 |
|
| Charles Schwab Investment Management | 12k | $20k | 2% | Dec 2024 |
|
| FMR | 11k | $17k | -72% | Dec 2024 |
|
| Tower Research Capital | 3.6k | $6.0k | 94% | Dec 2024 |
|
| Advisor Group Holdings | 1.5k | $2.6k | 0% | Dec 2024 |
|
| Point72 | 564.00 | $925.975200 | -92% | Dec 2024 |
|
| Bank of America Corporation | 251.00 | $411.991400 | 26% | Dec 2024 |
|
| SRS Capital Advisors | 235.00 | $386.011000 | -21% | Dec 2024 |
|
| Farther Finance Advisors | 108.00 | $135.000000 | 0% | Mar 2025 |
|
| NISA Investment Advisors | 99.00 | $162.003600 | 0% | Dec 2024 |
|
| SBI Securities | 3.00 | $5.000100 | 100% | Dec 2024 |
|
Who sold out of Ikena Oncology?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Acuitas Investments | Sep 2024 | 450k | $778k |
| Marquette Asset Management | Dec 2024 | 73k | $120k |
| Susquehanna International | Sep 2024 | 57k | $99k |
| Springbok Capital Management | Sep 2024 | 51k | $88k |
| ADAR1 Capital Management | Sep 2024 | 45k | $77k |
| Jane Street | Sep 2024 | 37k | $65k |
| Corsair Capital Management | Sep 2024 | 25k | $43k |
| Qube Research & Technologies | Sep 2024 | 17k | $30k |
| LPL Financial | Sep 2024 | 12k | $21k |
| Russell Investments | Sep 2024 | 2.7k | $4.7k |